Akça ÖF:. Disappearence of encopretic symptoms in treatment of attention deficit hyperactivity disorder with methylphenidate extended release medication: Two case reports. Klinik Psikiyatri, 14:115–118. 2011.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders4thText Revision (DSM-IV-TR)Washington (DC): American Psychiatric Association, 2000.
3.
BilgiçA. The possible effect of methylphenidate on secondary encopresis in children with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry, 35:647. 2011.
HergünerS, HergünerA. Atomoxetine for encopresis in 2 children with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol, 32:302–303. 2012.
6.
HuangWJ, ChienEJ, YehJY, ChenJJ, ChiaoYC, WangPS, ChangFY, DoongML. The roles of dopamine receptor and adrenoreceptor on the inhibition of gastric emptying and intestinal transit by amphetamine in male rats. Chinese J Physiol, 55:259–266. 2012.
7.
LiZS, SchmaussC, CuencaA, RatcliffeE, GershonMD. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D 2 receptor: analysis of dopamine receptor expression, location, development, and function in wild- type and knock-out mice. J Neurosci, 26:2798–2807. 2006.
MendhekarDN, GuptaN. Use of sertraline in childhood retentive encopresis. Ann Pharmacother, 44:395. 2010.
10.
MikkelsenEJ. Modern approaches to enuresis and encopresis. Child and Adolescent Psychiatry: A Comprehensive Textbook.LewisM. Philadelphia: Lippincott Williams & Wilkins, 2002; 700–710.
11.
SiomopoulosV. Psychogenic encopresis treated with imipramine. JAMA, 235:1842. 1976.
12.
YilmazS, BilgiçA, HergünerS. Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol, 2013Epub ahead of print10.1089/cap.2013.0023.
